Outcomes by Design Ep. 11 | Food Noise Is Real. And Science Is Finally Catching Up.

What exactly is “food noise” — and why are so many people talking about it in the age of GLP-1s? In this episode of Outcomes by Design, Dr. Kristin Baier sits down with Michelle Cardel, PhD, MS, RD, a leading nutrition scientist, registered dietitian, and obesity researcher, to explore the evolving science of food noise, nutrition, and long-term obesity care. Dr. Cardel explains why food noise is different from hunger or cravings, what researchers are learning about how GLP-1 medications may affect persistent thoughts about food, and why having a validated way to measure food noise matters for both patients and clinicians. They also discuss an important reality of GLP-1 treatment: when appetite decreases significantly, nutrition becomes more important — not less. From protein, fiber, and hydration to maintaining adequate nutrition and finding the right medication dose, they explore why personalized nutritional support should be a core part of treatment. The conversation also covers: • Why obesity is not a failure of willpower • What happens to food noise on GLP-1 medications • The emerging science behind measuring food noise • Why “just eat more protein” oversimplifies GLP-1 nutrition • The role of registered dietitians in obesity care • How parents can talk about weight without reinforcing stigma • Why obesity care should be treated as long-term chronic condition management • The importance of personalization beyond the number on the scale The takeaway: effective obesity care isn’t medication OR lifestyle. It’s about bringing together the right clinical treatment, nutrition, behavioral support, and ongoing personalization to help people build outcomes they can sustain. Subscribe to Outcomes by Design for more conversations with clinicians, researchers, and healthcare leaders shaping the future of cardiometabolic and obesity care. #GLP1 #FoodNoise #ObesityCare #Nutrition #WeightManagement #CardiometabolicHealth #OutcomesByDesign